WP
CRBU icon

Westmount Partners’s Caribou Biosciences CRBU Stock Holding History

Westmount Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,609
Closed -$37.3K – 280
2026
Q1 		$37.3K Buy
+19,609
New +$33.7K 0.01% 261

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Westmount Partners's CRBU Position: Q2 2026 in Review

Westmount Partners sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 19,609 shares — an estimated $37.3K sold.

Westmount Partners first reported a position in CRBU in Q1 2026 and held it in 1 quarter. The position peaked at $37.3K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Westmount Partners reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Westmount Partners sold 19,609 Caribou Biosciences shares in Q2 2026, an estimated $37.3K.
  • Westmount Partners first reported a position in Caribou Biosciences in Q1 2026 and held it in 1 quarter.
  • Westmount Partners's Caribou Biosciences position peaked at $37.3K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Westmount Partners's 13F filing for Q2 2026, filed 7 Jul 2026.